Pulmonary hypertension in preterm infants: results of a prospective screening program

C G Weismann1,2, J D Asnes1, A Bazzy-Asaad3

  • 1Department of Pediatrics, Division of Pediatric Cardiology, Section of Pediatric Cardiology, Yale University School of Medicine, New Haven, CT, USA.

Insights

Pulmonary hypertension (PH) is more common in preterm infants with bronchopulmonary dysplasia (BPD). Necrotizing enterocolitis (NEC) is a key factor associated with PH in these infants, potentially refining screening protocols.

Area of Science:

  • Neonatal Medicine
  • Pediatric Cardiology
  • Respiratory Medicine

Background:

  • Pulmonary hypertension (PH) poses a significant risk in preterm infants.
  • Identifying risk factors and optimizing screening for PH in vulnerable neonates is crucial.

Purpose of the Study:

  • To determine the prevalence of PH in preterm infants.
  • To identify factors associated with PH in preterm infants with and without bronchopulmonary dysplasia (BPD).

Main Methods:

  • Prospective echocardiographic screening was performed on preterm infants (<32 weeks' gestational age).
  • Infants were categorized into two groups: those with BPD and those without BPD but with risk factors for PH.
  • Associations between clinical factors (e.g., necrotizing enterocolitis, intraventricular hemorrhage) and PH were analyzed.

Main Results:

  • PH prevalence was higher in infants with BPD (28%) compared to those without BPD (11%).
  • In infants with BPD, lower birth weight, lower gestational age, necrotizing enterocolitis (NEC), severe intraventricular hemorrhage (IVH), atrial septal defect (ASD), and mortality were associated with PH.
  • NEC was the only identified factor associated with PH in infants without BPD.

Conclusions:

  • PH in preterm infants is associated with NEC, regardless of BPD status.
  • In preterm infants with BPD, factors like prematurity, IVH, ASD, and mortality are also linked to PH.
  • Targeted screening, focusing on infants with NEC and specific BPD criteria, could improve efficiency and reduce unnecessary echocardiograms.
Abstract

Related Concept Videos

Pulmonary Function Tests01:25

Pulmonary Function Tests

Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
946
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
745
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
578
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
1.0K